Scholarly Index
Joshua J. Gagne
Johnson & Johnson (United States); 10,103 total citations; 283 total publications; best world rank #66
Johnson & Johnson (United States)
10,103Total citations
283Total publications
49H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmaceutical Economics and Policy | Lifetime | 112 | US 61 | 98.03 |
| Pharmaceutical studies and practices | Lifetime | 245 | US 123 | 97.85 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 66 | US 24 | 97.26 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 989 | US 449 | 97.96 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 365 | US 149 | 97.14 |
| Medication Adherence and Compliance | Lifetime | 226 | US 141 | 96.53 |
| Pharmaceutical industry and healthcare | Lifetime | 195 | US 120 | 93.41 |
| Statistical Methods in Clinical Trials | Lifetime | 606 | US 315 | 93.92 |
| Advanced Causal Inference Techniques | Lifetime | 267 | US 180 | 93.27 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 903 | US 229 | 83.43 |
| Statistical Methods in Clinical Trials | 2021-2025 | 746 | US 318 | 72.16 |
| Medication Adherence and Compliance | 2021-2025 | 831 | US 278 | 70.80 |
| Pharmaceutical Economics and Policy | 2021-2025 | 976 | US 308 | 69.83 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 480 | US 81 | 65.22 |